New data examine stents and bypass surgery in patients with 3VD and LMD
Newly reported data presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF) from the SYNTAX clinical trial (SYNergy Between PCI With TAXUS and Cardiac Surgery) reveal similar safety and efficacy outcomes when the use of a drug-eluting stent is compared to heart bypass surgery in patients with left main disease. Rates of major adverse cardiac and cerebrovascular events (MACCE) in patients with left main disease who received a stent were comparable with those who received bypass surgery (15.8% vs. 13.7% respectively). In addition, the overall safety measures of death, stroke and heart attack were similar: 7.0% for the patients that received a stent and 9.2% for the patients that received bypass surgery. Most importantly, patients who received stents rather than bypass surgery had fewer strokes at 1 year (0.3% vs. 2.7%, p=0.009), with similar rates of death (4.2% vs. 4.4 % respectively).
In patients with three-vessel disease, safety measures were comparable; however, the data reveal that patients who received angioplasty did show higher rates of revascularization and MACCE than those who received bypass surgery. In this group, the rate of revascularization in the stent group was higher (14.7% vs 5.4%, P<0.001). The overall rates of death, heart attack or stroke were similar in the 2 groups, however (7.9% vs 6.4%).
Data from the SYNTAX clinical trial also yielded a new tool to measure the complexity of coronary artery disease: The SYNTAX Score. The raw SYNTAX score is an effective predictor of major adverse coronary and cerebrovascular events, MACCE, according to the study. The trial data presented at TCT was used as part of calculating the score.
"The SYNTAX score is a new, innovative tool to describe the complexity of vasculature," said Patrick W. Serruys, MD, PhD, head of the Department of Interventional Cardiology at University Hospital Rotterdam, Netherlands and principal investigator of the study.
"SYNTAX has shown that TAXUS stents can be used safely rather than bypass surgery in the most complicated patients with coronary artery disease, those with left main and triple vessel disease." said Gregg W. Stone, MD, CRF Chairman, Professor of Medicine and the Director of Research and Education, Center for Interventional Vascular Therapy, NewYork-Presbyterian Hospital, Columbia University Medical Center. "The trade-off of 8 additional repeat revascularization procedures to prevent 2 strokes is more than acceptable. Moreover, the SYNTAX score will assist in assessing and determining whether stents or surgery are most appropriate for individual patients based on the severity of their disease."
- EXCEL trial will determine safety and efficacy of drug-eluting stents vs. bypass surgerySun, 14 Mar 2010, 6:14:26 EDT
- Drug-eluting stents better than bare-metal stents for heart attack patientsFri, 25 Sep 2009, 15:35:45 EDT
- Study examines use of stent with bioabsorbable polymerTue, 21 Sep 2010, 8:43:32 EDT
- Leaders trial: 3-year data on stent with biodegradable polymer to be presented at TCT 2010Tue, 21 Sep 2010, 8:43:35 EDT
- UCLA study compares bypass surgery to angioplastyTue, 13 Apr 2010, 12:52:52 EDT
Articles on the same topic
- Study shows safety and efficacy of blood flow reversal system used during carotid stentingThu, 16 Oct 2008, 16:22:27 EDT
- Study reveals embolic neuroprotection system reduces risk of cardiac eventsThu, 16 Oct 2008, 16:22:24 EDT
- Drug-eluting stents more effective, equally as safe as bare metal stents in clinical trialWed, 15 Oct 2008, 12:22:35 EDT
- Late-breaking results of clinical trial on therapeutic endovascular cooling reported at TCT 2008Wed, 15 Oct 2008, 7:21:24 EDT
- 12-month ATLANTA trial data show sustained benefit of Catania StentWed, 15 Oct 2008, 7:21:21 EDT
- Study reveals embolic neuroprotection system reduces risk of cardiac eventsfrom PhysorgThu, 16 Oct 2008, 17:07:50 EDT
- Drug-eluting Stents More Effective, Equally As Safe As Bare Metal Stents, Clinical Trial Suggestsfrom Science DailyWed, 15 Oct 2008, 13:36:30 EDT
- New data examine stents and bypass surgery in patients with 3VD and LMDfrom PhysorgWed, 15 Oct 2008, 7:21:10 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Which qubit my dear? New method to distinguish between neighbouring quantum bits
- Chemical probe confirms that body makes its own rotten egg gas, H2S, to benefit health
- Exposure to high pollution levels during pregnancy may increase risk of having child with autism
- IQ link to baby's weight gain in first month
- Personality test finds some mouse lemurs shy, others bold
- Even with defects, graphene is strongest material in the world
- Detection of the cosmic gamma ray horizon: Measures all the light in the universe since the Big Bang
- Genetic engineering alters mosquitoes' sense of smell
- Allosaurus fed more like a falcon than a crocodile, new study finds
- 'Popcorn' particle pathways promise better lithium-ion batteries